Noveome Biotherapeutics
Chad Glyde has a wealth of experience in the quality control field. Chad began their career in 2005 at Boehringer Ingelheim, where they held various roles, including Stability Program Supervisor - Quality Control, Stability Coordinator, and Chemist II. In 2014, they joined Hospira as a Quality Engineer - Marketed Product Quality. In 2016, they joined Noveome Biotherapeutics, Inc., where they held the roles of Director of Quality and Associate Director of Quality Control.
Chad Glyde received their Bachelor's degree in Chemistry from Ohio University between 1999 and 2004.
Noveome Biotherapeutics
Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.